Want to join the conversation?
Healthcare company $PKI said it sold its US prenatal screening laboratory services business PerkinElmer Labs/NTD to Eurofins Scientific. NTD generated approx. $20MM in revenue in 2015. The financial impact of the divestiture, excluding any potential gain on the sale, is not expected to have a material impact on $PKI's 2016 EPS guidance.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?